In a group of patients with stages IB–IV EC (n = 11; Figure 3D), TIMP2, CSF3, ENPP2, and SERPINF1 were significantly down-regulated in tumour tissue, by 4.9-fold, 9.6-fold, 10.2-fold, and 9.2-fold, respectively. This evidence concerns the gene SERPINF1 and neoplasm.